Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $612.7M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CVL | Ann: Civmec Euroz Hartleys Investor Presentation | 30/07/25 | 2 | 402 | |||
|
|||||||
CVL | Ann: Civmec Strengthens Orderbook by over $600 Million | 24/07/25 | 4 | 1.0K | |||
|
|||||||
CVL | Ann: Group Organisational Changes | 11/07/25 | 1 | 580 | |||
|
|||||||
CVL | Civmec consortium selected for Perth Sporting and Entertainment Precinct | 10/07/25 | 0 | 201 | |||
|
|||||||
CVL | Ann: Civmec Completes Acquisition of Luerssen Australia | 03/07/25 | 4 | 1.3K | |||
|
|||||||
CVL | Ann: Civmec Enters Binding Agreement to Acquire Luerssen AUS | 26/06/25 | 2 | 833 | |||
|
|||||||
CVL | Ann: Investor Presentation-Euroz Hartleys Industrial Forum | 18/06/25 | 2 | 939 | |||
|
|||||||
CVL | Ann: Investor Presentation Bell Potter Emerging Leaders Event | 02/06/25 | 1 | 769 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |